Public funding of pharmaceutical company R&D: where does the public interest lie?

Tagged :
Print
Text Size: Normal / Medium / Large
Printer-friendly versionPrinter-friendly version
Resource Language: 
English
Media Type: 
Online
Author: 
Martin Petit
Publisher: 
DES Action Canada
Publication Date: 
2000
Publication Place: 
Montreal, QC

Examines how pharmaceutical companies receive public funding for research and development (R&D) by way of tax benefits and federal public investment programs.

Available From: